Naranie Shanmuganathan

Dr

  • 26 Citations
  • 2 h-Index
20112019
If you made any changes in Pure these will be visible here soon.

Personal profile

Public Profile

Dr Shanmuganathan is a clinical and laboratory haematologist, conducting her PhD in leukaemia genomics. Not only is she a clinical research fellow at SAHMRI but she continues to consolidate her clinical experience as the Leukaemia Fellow at the Royal Adelaide Hospital. She is currently a recipient of the Dawes scholarship from the Royal Adelaide Hospital. 

Education/Academic qualification

Fellowship of the Royal Australasian College of Physicians

Fellowship of the Royal College of Pathologists of Australia

Bachelor's Degree, University of Adelaide

Network Recent external collaboration on country level. Dive into details by clicking on the dots.

Research Output 2011 2019

  • 26 Citations
  • 2 h-Index
  • 6 Article
  • 2 Review article

Bone marrow fibrosis associated with long-term imatinib therapy: resolution after switching to a second-generation TKI

Shanmuganathan, N., Branford, S., Hughes, T. & Hiwase, D., 12 Feb 2019, In : Blood advances. 3, 3, p. 370-374 5 p.

Research output: Contribution to journalArticle

2 Citations (Scopus)

Integrative genomic analysis reveals cancer-associated mutations at diagnosis of CML in patients with high-risk disease

Branford, S., Wang, P., Yeung, D., Thomson, D., Purins, A., Wadham, C., Shahrin, N. H., Marum, J. E., Nataren, N., Parker, W. T., Geoghegan, J., Feng, J., Shanmuganathan, N., Mueller, M. C., Dietz, C., Stangl, D., Donaldson, Z., Altamura, H., Georgievski, J., Braley, J. & 13 othersBrown, A., Hahn, C., Walker, I., Kim, S. H., Choi, S. Y., Park, S. H., Kim, D. W., White, D., Yong, A., Ross, D. M., Scott, H. S., Schreiber, A. W. & Hughes, T., 30 Aug 2018, In : Blood. 132, 9, p. 948-961 14 p.

Research output: Contribution to journalArticle

1 Citation (Scopus)

Long-term treatment-free remission of chronic myeloid leukemia with falling levels of residual leukemic cells

on behalf of the Australasian Leukaemia and Lymphoma Group (ALLG), 1 Dec 2018, In : Leukemia. 32, 12, p. 2572-2579 8 p.

Research output: Contribution to journalArticle

Molecular monitoring in CML: How deep? How often? How should it influence therapy?

Shanmuganathan, N. & Hughes, T., 30 Nov 2018, In : Hematology. 2018, 1, p. 168-176 9 p.

Research output: Contribution to journalArticle

Molecular monitoring in CML: how deep? How often? How should it influence therapy?

Shanmuganathan, N. & Hughes, T., 15 Nov 2018, In : Blood. 132, 20, p. 2125-2133 9 p.

Research output: Contribution to journalReview article